ArticleJournal of orthopaedic case reports2026
A Huge Recurrent Atypical Lipomatous Tumor (Well-Differentiated Liposarcoma) going in to Dedifferentiation 12 years after its First Detection.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Soft-tissue sarcoma (STS) being a rare malignancy, many times it undergoes inadequate surgery at first instance, leading to higher chances of recurrence. Atypical lipomatous tumor (ALT)/well-differentiated liposarcoma frequently undergoes first inadequate surgery leading to higher recurrence rate and sometimes getting converted to higher grade malignancy like dedifferentiated liposarcoma. Case Report: We had a 63-year-old female who presented with recurrent huge (dimension on final histopathology report: 29 × 24 × 11 cm) ALT of thigh after three prior surgeries over the span of 8 years. We resected it with wide margins and did a prophylactic nailing at second stage. Final histopathology report came out to be liposarcoma with foci of low-grade dedifferentiation (FNCLCC Grade 3). Patient received post-operative radiotherapy. At final follow-up of 35 months, our patient is recurrence free, doing all her daily routine activity independently. Conclusion: Ten percentages of the ALT dedifferentiate into dedifferentiated liposarcoma, which has 15-20% metastatic potential compared to almost nil in ALT which happened in our case. Due to this, we recommend treatment of ALT and all STS at a tertiary cancer care center by a multidisciplinary team as it requires adjuvant treatment also apart from surgery with adequate margins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.